Ad hoc announcement pursuant to Art. 53 LR

Burgdorf – Ypsomed (SIX: YPSN) announces changes to the Board of Directors. The founder and Chairman of the Board of Directors of the Ypsomed Group Dr. h.c. Willy Michel will not stand for re-election as Chairman and member of the Board of Directors at the upcoming Annual General Meeting on 29 June 2022. The Board of Directors proposes to the Annual General Meeting 2022 to elect the current member of the Board of Directors, Gilbert Achermann as new Chairman. Simon Michel will be nominated for election as a new member of the Board of Directors.

Dr. h.c. Willy Michel, Chairman of the Board of Directors, will step down from the Board of Directors of Ypsomed Holding AG at the Annual General Meeting 2022. The Board of Directors proposes to the Annual General Meeting 2022 to elect Gilbert Achermann as new Chairman of the Board of Directors. He has been a member of the Board of Directors of the Ypsomed Group since 2020 and is also Chairman of the Board of Directors of the Straumann Group, the global market leader in dental implantology, as well as a member of the Board of Directors of Julius Baer Group. He is a member of the supervisory board at IMD Lausanne, a member of the board of Swiss Medtech, and a committee member of the Basel Chamber of Commerce.

In appreciation and gratitude for his lifelong, entrepreneurial and successful commitment and in recognition of his decades of service as a person of responsibility around Ypsomed and formerly Disetronic, Dr. h.c. Willy Michel was appointed Honorary Chairman of the Ypsomed Group by the Board of Directors on 17 May 2022. This does not entail any function in a governing body.

Ypsomed has developed further in recent years and is ideally positioned with regard to the major challenges in the healthcare sector. Today, Ypsomed is both an innovation and a cost leader and operates in a market with enormous growth potential. With full conviction, I have come to the conclusion that now is the right time to pass the baton. Although it is not easy for me to say goodbye, I know that the course has been set for the successful future of Ypsomed,

Dr. h.c. Willy Michel explains his decision.

Together with his brother, my father invented the first insulin pump and developed Ypsomed from a local company into one of global importance and relevance. In our industry it takes perseverance, and the work is long-term oriented. My father always exercised foresight and prudence. He reacted to crises and upheavals with calm and great skill. He never lost sight of his vision of a world in which selfcare becomes simpler and easier,

CEO Simon Michel describes his father's achievements.

Furthermore, the Board of Directors proposes that Simon Michel be newly elected to the Board of Directors.

After an interruption of two years, it will again be possible to hold the Annual General Meeting of Ypsomed Holding AG physically. It will take place on 29 June 2022 in Burgdorf and on this occasion with a special festive agenda.

Thomas Kutt
Head of Investor Relations
Ypsomed Holding AG

Torna indietro